Daniel McEvoy
Corporate Officer/Principal at THOE HEAL
Profile
Daniel McEvoy is currently the Chief-Strategic Development at Thorne HealthTech, Inc. He previously worked as the Chief Financial Officer at Diversified Natural Products, Inc. and as the President at Onegevity Health LLC.
McEvoy received his undergraduate degree from Dartmouth College in 1982.
Daniel McEvoy active positions
| Companies | Position | Start |
|---|---|---|
| THOE HEAL | Corporate Officer/Principal | 31/07/2019 |
Former positions of Daniel McEvoy
| Companies | Position | End |
|---|---|---|
Diversified Natural Products, Inc.
 Diversified Natural Products, Inc. Chemicals: SpecialtyProcess Industries Diversified Natural Products, Inc. develops and commercializes products for chemical and healthcare industries. Its products include HEP-40, Oligo flex and xp-828L. The company was founded in 2003 and is headquartered in New York, NY. | Director of Finance/CFO | 05/02/2012 |
| Onegevity Health LLC | President | - |
Training of Daniel McEvoy
| Dartmouth College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Diversified Natural Products, Inc.
Diversified Natural Products, Inc. Chemicals: SpecialtyProcess Industries Diversified Natural Products, Inc. develops and commercializes products for chemical and healthcare industries. Its products include HEP-40, Oligo flex and xp-828L. The company was founded in 2003 and is headquartered in New York, NY. | Process Industries |
| Onegevity Health LLC | Technology Services |
Thorne HealthTech, Inc.
 Thorne HealthTech, Inc. Packaged SoftwareTechnology Services Thorne HealthTech, Inc. is engaged in the provision of a total system for wellness. It utilizes testing and data to create improved product quality and deliver personalized solutions to consumers, health professionals, and professional sports teams. It also helps pharmaceutical and biotechnology companies repurpose existing drugs and compounds, improve existing medications and develop new products. The company was founded by Paul Jacobson in 2010 and is headquartered in New York, NY. | Technology Services |
- Stock Market
- Insiders
- Daniel McEvoy
